Gene expression changes in 32DWT1 cells treated with ZnCl2
Gene . | UniGene no. . | Fold change with ZnCl2 . |
---|---|---|
Caveolin 2 | Mm.31915 | 0.15 |
Dffa | Mm.41433 | 0.26 |
Pdcd11 | Mm.41166 | 0.32 |
CIDE-A | Mm.449 | 0.36 |
RBBP4 | Mm.12145 | 2.67 |
IGF-II | Mm.3862 | 2.96 |
PTEN | Mm.220979 | 3.33 |
Cyclin A2 | Mm.4189 | 4.2 |
14-3-3 η | Mm.332314 | 4.22 |
Sfrp5 | Mm.103731 | 4.55 |
PCNA | Mm.7141 | 5.02 |
CDK4 | Mm.6839 | 6.23 |
Granzyme B | Mm.14874 | 10.72 |
NAIP | Mm.89961 | 11.2 |
ODC | Mm.34102 | 16.95 |
CBP | Mm.132238 | 17.53 |
MT-2 | Mm.147226 | 39 |
Granzyme A | Mm.15510 | — |
Sfrp2 | Mm.19155 | — |
BID | Mm.235081 | — |
A1 | Mm.196770 | — |
CDK6 | Mm.31672 | — |
Thrombospondin | Mm.4159 | — |
APEX | Mm.203 | — |
Gene . | UniGene no. . | Fold change with ZnCl2 . |
---|---|---|
Caveolin 2 | Mm.31915 | 0.15 |
Dffa | Mm.41433 | 0.26 |
Pdcd11 | Mm.41166 | 0.32 |
CIDE-A | Mm.449 | 0.36 |
RBBP4 | Mm.12145 | 2.67 |
IGF-II | Mm.3862 | 2.96 |
PTEN | Mm.220979 | 3.33 |
Cyclin A2 | Mm.4189 | 4.2 |
14-3-3 η | Mm.332314 | 4.22 |
Sfrp5 | Mm.103731 | 4.55 |
PCNA | Mm.7141 | 5.02 |
CDK4 | Mm.6839 | 6.23 |
Granzyme B | Mm.14874 | 10.72 |
NAIP | Mm.89961 | 11.2 |
ODC | Mm.34102 | 16.95 |
CBP | Mm.132238 | 17.53 |
MT-2 | Mm.147226 | 39 |
Granzyme A | Mm.15510 | — |
Sfrp2 | Mm.19155 | — |
BID | Mm.235081 | — |
A1 | Mm.196770 | — |
CDK6 | Mm.31672 | — |
Thrombospondin | Mm.4159 | — |
APEX | Mm.203 | — |
Listed are genes noted to be significantly up- or down-regulated upon WT1 induction in 32DWT1 cells, but not (with the exception of metallothionein) in 32DV4 cells treated with ZnCl2. Metallothionein was up-regulated in control cells, which is the expected response to treatment with heavy metal.
— indicates a gene that was expressed only after treatment with ZnCl2.